Literature DB >> 28794252

White matter hyperintensity reduction and outcomes after minor stroke.

Joanna M Wardlaw1, Francesca M Chappell2, Maria Del Carmen Valdés Hernández2, Stephen D J Makin2, Julie Staals2, Kirsten Shuler2, Michael J Thrippleton2, Paul A Armitage2, Susana Muñoz-Maniega2, Anna K Heye2, Eleni Sakka2, Martin S Dennis2.   

Abstract

OBJECTIVE: To assess factors associated with white matter hyperintensity (WMH) change in a large cohort after observing obvious WMH shrinkage 1 year after minor stroke in several participants in a longitudinal study.
METHODS: We recruited participants with minor ischemic stroke and performed clinical assessments and brain MRI. At 1 year, we assessed recurrent cerebrovascular events and dependency and repeated the MRI. We assessed change in WMH volume from baseline to 1 year (normalized to percent intracranial volume [ICV]) and associations with baseline variables, clinical outcomes, and imaging parameters using multivariable analysis of covariance, model of changes, and multinomial logistic regression.
RESULTS: Among 190 participants (mean age 65.3 years, range 34.3-96.9 years, 112 [59%] male), WMH decreased in 71 participants by 1 year. At baseline, participants whose WMH decreased had similar WMH volumes but higher blood pressure (p = 0.0064) compared with participants whose WMH increased. At 1 year, participants with WMH decrease (expressed as percent ICV) had larger reductions in blood pressure (β = 0.0053, 95% confidence interval [CI] 0.00099-0.0097 fewer WMH per 1-mm Hg decrease, p = 0.017) and in mean diffusivity in normal-appearing white matter (β = 0.075, 95% CI 0.0025-0.15 fewer WMH per 1-unit mean diffusivity decrease, p = 0.043) than participants with WMH increase; those with WMH increase experienced more recurrent cerebrovascular events (32%, vs 16% with WMH decrease, β = 0.27, 95% CI 0.047-0.50 more WMH per event, p = 0.018).
CONCLUSIONS: Some WMH may regress after minor stroke, with potentially better clinical and brain tissue outcomes. The role of risk factor control requires verification. Interstitial fluid alterations may account for some WMH reversibility, offering potential intervention targets.
Copyright © 2017 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.

Entities:  

Mesh:

Year:  2017        PMID: 28794252      PMCID: PMC5589793          DOI: 10.1212/WNL.0000000000004328

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  23 in total

1.  Improved optimization for the robust and accurate linear registration and motion correction of brain images.

Authors:  Mark Jenkinson; Peter Bannister; Michael Brady; Stephen Smith
Journal:  Neuroimage       Date:  2002-10       Impact factor: 6.556

2.  Evaluating the effect of change on change: a different viewpoint.

Authors:  Eyal Shahar
Journal:  J Eval Clin Pract       Date:  2009-02       Impact factor: 2.431

3.  Fast free-form deformation using graphics processing units.

Authors:  Marc Modat; Gerard R Ridgway; Zeike A Taylor; Manja Lehmann; Josephine Barnes; David J Hawkes; Nick C Fox; Sébastien Ourselin
Journal:  Comput Methods Programs Biomed       Date:  2009-10-08       Impact factor: 5.428

Review 4.  Longitudinal change of small-vessel disease-related brain abnormalities.

Authors:  Reinhold Schmidt; Stephan Seiler; Marisa Loitfelder
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

5.  Classification and natural history of clinically identifiable subtypes of cerebral infarction.

Authors:  J Bamford; P Sandercock; M Dennis; J Burn; C Warlow
Journal:  Lancet       Date:  1991-06-22       Impact factor: 79.321

6.  White matter edema at the early stage of cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy.

Authors:  François De Guio; Jean-François Mangin; Marco Duering; Stefan Ropele; Hugues Chabriat; Eric Jouvent
Journal:  Stroke       Date:  2014-11-04       Impact factor: 7.914

7.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging.

Authors:  F Fazekas; J B Chawluk; A Alavi; H I Hurtig; R A Zimmerman
Journal:  AJR Am J Roentgenol       Date:  1987-08       Impact factor: 3.959

8.  Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study.

Authors:  Ewoud J van Dijk; Niels D Prins; Henri A Vrooman; Albert Hofman; Peter J Koudstaal; Monique M B Breteler
Journal:  Stroke       Date:  2008-07-17       Impact factor: 7.914

Review 9.  The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis.

Authors:  Stéphanie Debette; H S Markus
Journal:  BMJ       Date:  2010-07-26

10.  Vascular risk factors, large-artery atheroma, and brain white matter hyperintensities.

Authors:  Joanna M Wardlaw; Michael Allerhand; Fergus N Doubal; Maria Valdes Hernandez; Zoe Morris; Alan J Gow; Mark Bastin; John M Starr; Martin S Dennis; Ian J Deary
Journal:  Neurology       Date:  2014-03-12       Impact factor: 9.910

View more
  33 in total

1.  Brain atrophy in cerebral small vessel diseases: Extent, consequences, technical limitations and perspectives: The HARNESS initiative.

Authors:  François De Guio; Marco Duering; Franz Fazekas; Frank-Erik De Leeuw; Steven M Greenberg; Leonardo Pantoni; Agnès Aghetti; Eric E Smith; Joanna Wardlaw; Eric Jouvent
Journal:  J Cereb Blood Flow Metab       Date:  2019-11-20       Impact factor: 6.200

2.  Cardiovascular Risk Factor Burden in Veterans and Non-Veterans with Parkinson Disease.

Authors:  Vikas Kotagal; Roger L Albin; Martijn L T M Müller; Nicolaas I Bohnen
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

3.  Cognitive consequences of regression of cerebral small vessel disease.

Authors:  Esther Mc van Leijsen; Mayra I Bergkamp; Ingeborg Wm van Uden; Sjacky Cooijmans; Mohsen Ghafoorian; Helena M van der Holst; David G Norris; Roy Pc Kessels; Bram Platel; Anil M Tuladhar; Frank-Erik de Leeuw
Journal:  Eur Stroke J       Date:  2018-12-21

4.  Blood pressure, glycemic control, and white matter hyperintensity progression in type 2 diabetics.

Authors:  Adam de Havenon; Jennifer J Majersik; David L Tirschwell; J Scott McNally; Gregory Stoddard; Natalia S Rost
Journal:  Neurology       Date:  2019-02-08       Impact factor: 9.910

5.  Rationale and design of a longitudinal study of cerebral small vessel diseases, clinical and imaging outcomes in patients presenting with mild ischaemic stroke: Mild Stroke Study 3.

Authors:  Una Clancy; Daniela Jaime Garcia; Michael S Stringer; Michael J Thrippleton; Maria C Valdés-Hernández; Stewart Wiseman; Olivia Kl Hamilton; Francesca M Chappell; Rosalind Brown; Gordon W Blair; Will Hewins; Emilie Sleight; Lucia Ballerini; Mark E Bastin; Susana Munoz Maniega; Tom MacGillivray; Kirstie Hetherington; Charlene Hamid; Carmen Arteaga; Alasdair G Morgan; Cameron Manning; Ellen Backhouse; Iona Hamilton; Dominic Job; Ian Marshall; Fergus N Doubal; Joanna M Wardlaw
Journal:  Eur Stroke J       Date:  2020-06-05

6.  Association of Cerebral Small Vessel Disease and Cognitive Decline After Intracerebral Hemorrhage.

Authors:  Marco Pasi; Lansing Sugita; Li Xiong; Andreas Charidimou; Gregoire Boulouis; Thanakit Pongpitakmetha; Sanjula Singh; Christina Kourkoulis; Kristin Schwab; Steven M Greenberg; Christopher D Anderson; M Edip Gurol; Jonathan Rosand; Anand Viswanathan; Alessandro Biffi
Journal:  Neurology       Date:  2020-10-16       Impact factor: 9.910

7.  Development of a protocol to assess within-subject, regional white matter hyperintensity changes in aging and dementia.

Authors:  Ahmed A Bahrani; Charles D Smith; Justin M Barber; Omar M Al-Janabi; David K Powell; Anders H Andersen; Brandon D Ramey; Erin L Abner; Larry B Goldstein; Zachary Winder; Brian T Gold; Linda Van Eldik; Donna M Wilcock; Gregory A Jicha
Journal:  J Neurosci Methods       Date:  2021-06-24       Impact factor: 2.987

8.  Mendelian Randomization Study of Obesity and Cerebrovascular Disease.

Authors:  Sandro Marini; Jordi Merino; Bailey E Montgomery; Rainer Malik; Catherine L Sudlow; Martin Dichgans; Jose C Florez; Jonathan Rosand; Dipender Gill; Christopher D Anderson
Journal:  Ann Neurol       Date:  2020-02-19       Impact factor: 10.422

9.  Small vessels, dementia and chronic diseases - molecular mechanisms and pathophysiology.

Authors:  Karen Horsburgh; Joanna M Wardlaw; Tom van Agtmael; Stuart M Allan; Mike L J Ashford; Philip M Bath; Rosalind Brown; Jason Berwick; M Zameel Cader; Roxana O Carare; John B Davis; Jessica Duncombe; Tracy D Farr; Jill H Fowler; Jozien Goense; Alessandra Granata; Catherine N Hall; Atticus H Hainsworth; Adam Harvey; Cheryl A Hawkes; Anne Joutel; Rajesh N Kalaria; Patrick G Kehoe; Catherine B Lawrence; Andy Lockhart; Seth Love; Malcolm R Macleod; I Mhairi Macrae; Hugh S Markus; Chris McCabe; Barry W McColl; Paul J Meakin; Alyson Miller; Maiken Nedergaard; Michael O'Sullivan; Terry J Quinn; Rikesh Rajani; Lisa M Saksida; Colin Smith; Kenneth J Smith; Rhian M Touyz; Rebecca C Trueman; Tao Wang; Anna Williams; Steven C R Williams; Lorraine M Work
Journal:  Clin Sci (Lond)       Date:  2018-04-30       Impact factor: 6.124

Review 10.  William M. Feinberg Award for Excellence in Clinical Stroke: Small Vessel Disease; a Big Problem, But Fixable.

Authors:  Joanna M Wardlaw
Journal:  Stroke       Date:  2018-06-12       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.